<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:epub="http://www.idpf.org/2007/ops" lang="en">
<head>
<meta http-equiv="default-style" content="application/xhtml+xml; charset=utf-8"/>
<title>Brunner &#38; Suddarth&#8217;s Textbook of Medical-Surgical Nursing, 15e</title>
<link rel="stylesheet" type="text/css" href="style.css"/>
</head>
<body epub:type="bodymatter">
<div id="main_container">
<section epub:type="division">
<h4 class="h4" id="s1796">Diagnostic Evaluation</h4>
<p class="nonindent">A wide range of diagnostic studies may be performed in patients with hepatic disorders. The nurse should educate the patient about the purpose, what to expect, and any possible side effects related to these examinations prior to testing. The nurse should note trends in results because they provide information about disease progression as well as the patient&#x2019;s response to therapy.</p>
<h5 class="h5" id="s1797">Liver Function Tests</h5>
<p class="nonindent">More than 70% of the parenchyma of the liver may be damaged before liver function test results become abnormal. Function is generally measured in terms of serum enzyme activity (i.e., serum aminotransferases, alkaline phosphatase, lactic dehydrogenase) and serum concentrations of proteins (albumin and globulins), bilirubin, ammonia, clotting factors, and lipids (<a href="c43-sec28.xhtml#bib3334">Hammer &#x0026; McPhee, 2019</a>; <a href="c43-sec28.xhtml#bib3334">Mansour &#x0026; McPherson, 2018</a>; <a href="c43-sec28.xhtml#bib3334">Sanyal et al., 2018</a>; <a href="c43-sec28.xhtml#bib3318">Wendon, Cordoba, Dhawan, et al., 2017</a>). Several of these tests may be helpful for assessing patients with liver disease. However, the nature and extent of hepatic dysfunction cannot be determined by these tests alone, because other disorders can affect test results.</p>
<p class="indent">Serum aminotransferases are sensitive indicators of injury to the liver cells and are useful in detecting acute liver disease such as hepatitis. Alanine aminotransferase (ALT), aspartate aminotransferase (AST), and gamma-glutamyl transferase (GGT) (also called gamma-glutamyl transpeptidase [GGTP]) are the most frequently used tests of liver damage (<a href="c43-sec28.xhtml#bib3334">Friedman &#x0026; Martin, 2018</a>; <a href="c43-sec28.xhtml#bib3334">Maher &#x0026; Schreibman, 2018</a>; <a href="c43-sec28.xhtml#bib3334">Schiff et al., 2018</a>). ALT levels increase primarily in liver disorders and may be used to monitor the course of hepatitis or cirrhosis or the effects of treatments that may be toxic to the liver. AST is present in tissues that have high metabolic activity; therefore, the level may be increased if there is damage to or death of tissues of organs such as the heart, liver, skeletal muscle, and kidney. Although not specific to liver disease, levels of AST may be increased in cirrhosis, hepatitis, and liver cancer. Increased GGT levels are associated with cholestasis but can also be due to alcoholic liver disease. Although the kidney has the highest level of the enzyme, the liver is considered the source of normal serum activity. The test determines liver cell dysfunction and is a sensitive indicator of cholestasis. Its main value in liver disease is confirming the hepatic origin of an elevated alkaline phosphatase level. Common liver function tests are summarized in <a href="#tt43-1">Table 43-1</a>, additional laboratory values can be found in Appendix A on <img class="m" src="images/thepoint.jpg" alt=""/>.</p>
<h5 class="h5" id="s1798">Liver Biopsy</h5>
<p class="nonindent">Liver biopsy is the removal of a small amount of liver tissue, usually through needle aspiration. It permits examination of liver cells. The most common indication is to evaluate diffuse disorders of the parenchyma and to diagnose space-occupying lesions. Liver biopsy is especially useful when clinical findings and laboratory tests are not diagnostic. Though rare due to the radiologic guidance now available, peritonitis caused by blood or bile after liver biopsy is the most common complication; therefore, coagulation studies are obtained, their values are noted, and abnormal results are treated before liver biopsy is performed (<a href="c43-sec28.xhtml#bib3334">Schiff et al., 2018</a>). Other techniques for liver biopsy are preferred if <strong><button class="vsm-bubble-widget glossary-term" data-bubble-content="&lt;b&gt;ascites:&lt;/b&gt; an accumulation of serous fluid in the peritoneal cavity">ascites</button></strong> (an accumulation of albumin-rich fluid in the peritoneal cavity) or coagulation abnormalities exist. A liver biopsy can be performed percutaneously with ultrasound guidance or transvenously through the right internal jugular vein to right hepatic vein under fluoroscopic control. Liver biopsy can also be performed laparoscopically.</p>
<div class="pagebreak_container"><span class="pagebreak">p. 1369</span><div class="rule"></div><span id="page1370" class="pagebreak" epub:type="pagebreak" title="1370">p. 1370</span></div>
<p class="BX18MTXTMFIRST" id="box1370"><img class="m" src="images/377-1.png" alt=""/> For the procedural guidelines for assisting with percutaneous liver biopsy, go to <a href="http://thepoint.lww.com/Brunner15e">thepoint.lww.com/Brunner15e</a>.</p>
<div class="table">
<table class="tbo" id="tt43-1">
<colgroup>
<col style="width:20%"></col>
<col style="width:80%"></col>
</colgroup>
<tr>
<td class="tdnum"><p class="tnum"><strong>TABLE&#x00A0;43-1</strong></p></td>
<td><p class="tcaption">Common Laboratory Tests to Assess Liver Function</p></td>
</tr>
</table>
<table class="table">
<tr><td class="thead"><p class="T2">Test</p></td>
<td class="thead"><p class="T2">Normal</p></td>
<td class="thead"><p class="T2">Clinical Functions</p></td></tr>
<tr><td colspan="3" class="td76">
<p class="tbodyleft"><strong>Pigment Studies</strong></p></td></tr>
<tr><td class="td76">
<p class="tbodyleft">Serum bilirubin, direct</p>
<p class="tbodyleft">Serum bilirubin, total</p>
<p class="tbodyleft">Urine bilirubin</p>
<p class="tbodyleft">Urine urobilinogen</p>
<p class="white1"></p>
<p class="tbodyleft">Fecal urobilinogen (infrequently used)</p></td>
<td class="td76">
<p class="tbodyleft">0.1&#x2013;0.4 mg/dL (1.7&#x2013;3.7 mcmol/L)</p>
<p class="tbodyleft">0.3&#x2013;1 mg/dL (5&#x2013;17 mcmol/L)</p>
<p class="tbodyleft">&#x003C;0.25 mg/24 h (&#x003C;0.42 mcmol/24 h)</p>
<p class="tbodyleft">(Urine urobilinogen) 0.05&#x2013;2.5 mg/24 h (0.5&#x2013;4 Ehrlich U/24 h)</p>
<p class="tbodyleft">(Fecal urobilinogen) 50&#x2013;300 mg/24 h (100&#x2013;400 Ehrlich U/100 g)</p></td>
<td class="td76">
<p class="tbodyleft">These studies measure the ability of the liver to conjugate and excrete bilirubin. Results are abnormal in liver and biliary tract disease and are associated with jaundice clinically.</p></td></tr>
<tr><td class="td76">
<p class="tbodyleft"><strong>Protein Studies</strong></p></td>
<td class="td76"/><td class="td76"/></tr>
<tr><td class="td76">
<p class="tbodyleft">Total serum protein</p>
<p class="tbodyleft">Serum albumin</p>
<p class="tbodyleft">Serum globulin</p>
<p class="tbodyleft">Serum protein electrophoresis</p>
<p class="tbodyleft">Albumin</p>
<p class="tbodyleft">&#x03B1;<sub>1</sub>-Globulin</p>
<p class="tbodyleft">&#x03B1;<sub>2</sub>-Globulin</p>
<p class="tbodyleft">&#x03B2;-Globulin</p>
<p class="tbodyleft">&#x03B3;-Globulin</p>
<p class="tbodyleft">A/G ratio</p></td>
<td class="td76">
<p class="tbodyleft">7&#x2013;7.5 g/dL (70&#x2013;75 g/L)</p>
<p class="tbodyleft">3.5&#x2013;5.2 g/dL (35&#x2013;52 g/L)</p>
<p class="tbodyleft">2.3&#x2013;3.5 g/dL (23&#x2013;35 g/L)</p>
<p class="white1"></p>
<p class="tbodyleft">3.5&#x2013;5.2 g/dL (35&#x2013;52 g/L)</p>
<p class="tbodyleft">0.1&#x2013;0.3 g/dL (1&#x2013;3 g/L)</p>
<p class="tbodyleft">0.6&#x2013;1 g/dL (6&#x2013;10 g/L)</p>
<p class="tbodyleft">0.5&#x2013;1 g/dL (5&#x2013;10 g/L)</p>
<p class="tbodyleft">0.6&#x2013;1.3 g/dL (6&#x2013;13 g/L)</p>
<p class="tbodyleft">A &#x003E; G or 1.5:1&#x2013;2.5:1</p></td>
<td class="td76">
<p class="tbodyleft">Proteins are manufactured by the liver. Their levels may be affected in a variety of liver impairments: albumin is affected in cirrhosis, chronic hepatitis, edema; and ascites; globulins are affected in cirrhosis, liver disease, chronic obstructive jaundice, and viral hepatitis.</p>
<p class="white1"></p>
<p class="white1"></p>
<p class="white1"></p>
<p class="white1"></p>
<p class="tbodyleft">A/G ratio is reversed in chronic liver disease (decreased albumin and increased globulin).</p></td></tr>
<tr><td class="td1">
<p class="tbodyleft"><strong>Prothrombin Time/International Normalized Ratio (PT/INR)</strong></p></td>
<td class="td1">
<p class="tbodyleft">100% or 11&#x2013;13 s/the INR is a calculation based on results of the PT. INR levels &#x003C;1.1 are considered normal</p></td>
<td class="td1">
<p class="tbodyleft">Prothrombin time and INR may be prolonged in liver disease. It is an indicator of synthetic hepatic function. It will not return to normal with vitamin K in severe liver cell damage.</p></td></tr>
<tr><td class="td1">
<p class="tbodyleft"><strong>Serum Alkaline Phosphatase</strong></p></td>
<td class="td1">
<p class="tbodyleft">Varies with method:</p>
<p class="tbodyleft"><em>Adults:</em> 52&#x2013;142 U/L</p></td>
<td class="td1">
<p class="tbodyleft">Serum alkaline phosphatase is manufactured in bones, liver, kidneys, and intestine and excreted through biliary tract. In the absence of bone disease, it is a sensitive measure of biliary tract obstruction. Results may vary because this test is temperature and lab method dependent.</p></td></tr>
<tr><td class="td76">
<p class="tbodyleft"><strong>Serum Aminotransferase Studies</strong></p></td>
<td class="td76"/><td class="td76"/></tr>
<tr><td class="td76">
<p class="tbodyleft">AST</p>
<p class="tbodyleft">ALT</p></td>
<td class="td76">
<p class="tbodyleft">10&#x2013;40 U/mL (0.34&#x2013;0.68 U/L)</p>
<p class="tbodyleft">8&#x2013;40 U/mL (0.14&#x2013;0.68 U/L)</p></td>
<td class="td76">
<p class="tbodyleft">The studies are based on release of enzymes from damaged liver cells. These enzymes are elevated in liver cell damage. Normal values may differ in men and women.</p></td></tr>
<tr><td class="td1">
<p class="tbodyleft"><strong>GGT, GGTP</strong></p></td>
<td class="td1">
<p class="tbodyleft">0&#x2013;30 U/L IU/L</p></td>
<td class="td1">
<p class="tbodyleft">Values are elevated in alcohol abuse and markers for biliary cholestasis.</p></td></tr>
<tr><td class="td1">
<p class="tbodyleft"><strong>LDH</strong></p></td>
<td class="td1">
<p class="tbodyleft">100&#x2013;200 units (100&#x2013;225 U/L)</p></td>
<td class="td1">&#x00A0;</td></tr>
<tr><td class="td1">
<p class="tbodyleft"><strong>Ammonia (plasma)</strong></p></td>
<td class="td1">
<p class="tbodyleft">15&#x2013;45 mcg/dL (11&#x2013;32 mcmol/L)</p></td>
<td class="td1">
<p class="tbodyleft">Liver converts ammonia to urea. Ammonia level rises in liver failure.</p></td></tr>
<tr><td class="td76">
<p class="tbodyleft"><strong>Cholesterol</strong></p></td>
<td class="td76"/><td class="td76"/></tr>
<tr><td class="td76">
<p class="tbodyleft">Ester</p>
<p class="white1"></p>
<p class="tbodyleft">HDL</p>
<p class="tbodyleft">LDL</p></td>
<td class="td76">
<p class="tbodyleft">60&#x2013;70% of total cholesterol, fraction of total cholesterol 0.60&#x2013;0.70</p>
<p class="tbodyleft"><em>Male:</em> 35&#x2013;70 mg/dL; <em>Female:</em> 35&#x2013;85 mg/dL</p>
<p class="tbodyleft">&#x003C;130 mcg/dL</p></td>
<td class="td76">
<p class="tbodyleft">Cholesterol levels are elevated in biliary obstruction and decreased in parenchymal liver disease.</p></td></tr>
</table>
<p class="TABLEpLEGEND">A/G, albumin/globulin; ALT, alanine aminotransferase; AST, aspartate aminotransferase; GGT, gamma-glutamyl transferase; GGTP, gamma-glutamyl transpeptidase; HDL, high-density lipoprotein; LDH, lactate dehydrogenase; LDL, low-density lipoprotein.</p>
<p class="tablesource">Adapted from Fischbach, F., &#x0026; Fischbach, M. (2018). <em>A manual of laboratory and diagnostic tests</em> (10th ed.). Philadelphia, PA: Wolters Kluwer.</p>
</div>
<h5 class="h5" id="s1799">Other Diagnostic Tests</h5>
<p class="nonindent">Ultrasonography, computed tomography (CT) scans, and magnetic resonance imaging (MRI) are used to identify normal structures and abnormalities of the liver and biliary tree. A radioisotope liver scan may be performed to assess liver size, blood flow, and obstruction. Noninvasive liver stiffness measurements or elastography uses ultrasound-based vibration and scanning to identify liver fibrosis and determine its extent. Magnetic resonance elastography uses mechanical shear waves to identify stiff tissue (<a href="c43-sec28.xhtml#bib3334">Schiff et al., 2018</a>). Liver fibrosis and other liver diseases can be identified, evaluated and monitored with a variety of other noninvasive studies. These studies may reduce the need for liver biopsy (<a href="c43-sec28.xhtml#bib3334">Friedman &#x0026; Martin, 2018</a>; <a href="c43-sec28.xhtml#bib3334">Schiff et al., 2018</a>).</p>
<p class="indent">Laparoscopy (insertion of a fiberoptic endoscope through a small abdominal incision) is used to examine the liver and other pelvic structures. It is also used to perform guided liver biopsy, to determine the cause of ascites, and to diagnose and stage tumors of the liver and other abdominal organs.</p>
</section>
</div>
</body>
</html>